谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Final Top-Line Results of the BGBC008 Phase II, Multicenter Study of Bemcentinib and Pembrolizumab (bem Plus Pembro) in Second-Line (2L) Advanced Non-Squamous (NS) Non-Small Cell Lung Cancer (NSCLC) (NCT03184571)

E. Felip,M. G. Krebs,E. Carcereny,K. B. Smeland,E. Arriola,C. Llacer Perez,J. Thompson,L. Paz-Ares,M. Domine Gomez, J. R. Olivares,N. Vinolas Segarra,M. R. Garcia-Campelo,A. L. O. Ortega Granados,M. Chisamore,D. Micklem,N. McCracken, A. Rayford, C. Oliva, C. Gorcea-Carson,J. Spicer

ANNALS OF ONCOLOGY（2023）

引用 0|浏览17
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要